Drug Shortage Report for BEPREVE
| Report ID | 246290 |
| Drug Identification Number | 02456532 |
| Brand name | BEPREVE |
| Common or Proper name | B&LCN BEPREVE 1.5% SOLN 5ML |
| Company Name | BAUSCH & LOMB INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BEPOTASTINE BESILATE |
| Strength(s) | 1.5% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 |
| ATC code | S01 |
| ATC description | L3 not assigned |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-12-20 |
| Actual start date | |
| Estimated end date | 2025-01-15 |
| Actual end date | 2025-01-08 |
| Shortage status | Resolved |
| Updated date | 2025-01-09 |
| Company comments | Delay of distribution of the drug |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-01-09 | English | Compare |
| v5 | 2025-01-07 | French | Compare |
| v4 | 2025-01-07 | English | Compare |
| v3 | 2024-12-21 | English | Compare |
| v2 | 2024-12-20 | French | Compare |
| v1 | 2024-12-20 | English | Compare |
Showing 1 to 6 of 6